Evaluating BNP for Heart Failure Diagnosis in Primary Care
Author Information
Author(s): Bhatia Gurbir S, Sosin Michael D, Stubley Jane, Patel Jeetesh V, Hughes Elizabeth A, Gibbs Rebecca, Davis Russell C
Primary Institution: Sandwell & West Birmingham Hospitals NHS Trust
Hypothesis
Can B-type natriuretic peptide (BNP) assay accurately validate a heart failure register in primary care?
Conclusion
Half of the patients registered as having heart failure did not have significant cardiac dysfunction, and BNP assay is not a reliable tool for diagnosis in this context.
Supporting Evidence
- 30 patients were incorrectly coded as having heart failure.
- 70 out of 112 previously investigated patients were confirmed to have heart failure.
- Only 50.2% of patients on the register had objective evidence of heart failure.
- BNP was poor at discriminating between those with and without systolic dysfunction.
Takeaway
Doctors wanted to see if a blood test called BNP could help them figure out if patients really had heart failure. They found that many patients didn't actually have heart problems.
Methodology
A register validation audit was conducted in a single general practice, involving echocardiography and BNP assays on patients registered with heart failure.
Potential Biases
Potential bias due to the small sample size and the specific population of a single practice.
Limitations
The study was limited to a single practice and may not be generalizable to other settings.
Participant Demographics
Mean age of participants was 77 years, with 53.6% being female.
Statistical Information
P-Value
0.010
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website